Trial intelligence / Profile preview

Topiramate for Hospitalized Patients With Alcoholism

NCT01135602Phase 4Unknown

Sponsor
Chiang Mai University
Start
Jul 2010
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of topiramate in alcohol dependence, sponsored by Chiang Mai University. Primary endpoint: Cognition at 12 weeks. Status: unknown.

02

Drugs

topiramate
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT01135602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01135602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call